EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

The Mediterranean Diet and Inflammatory Bowel Disease: A Comprehensive Systematic Review and Meta‐Analysis

Muhammad Shahzil, Syeda Kanza Kazmi, Minahel Shehzadi, Fariha Hasan, Mohammad Waqas Danish, Muhammad Saad Faisal, Justin Canakis, Kofi Clarke

Gastroenterology Research and Practice · 2026-01 · 2026 (1)

DOI: 10.1155/grp/2994340 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Gastroenterology Research and Practice, online erschienen am 17.03.2026. Verfasst von Muhammad Shahzil und 7 weiteren Autor:innen. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Pennsylvania State University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Diet significantly influences the progression of inflammatory bowel disease (IBD). The Mediterranean diet (MD), characterized by high consumption of fruits, vegetables, healthy fats, lean proteins, and limited intake of processed foods, is recommended as adjunctive therapy. This meta‐analysis is aimed at evaluating existing data on dietary management in ulcerative colitis (UC) and assessing the effectiveness of MD in achieving symptomatic remission or improvement in IBD patients compared with other dietary interventions.

Methods

Following Cochrane and PRISMA guidelines, we compared MD with alternative dietary interventions in IBD patients. Randomized controlled trials (RCTs) were identified through comprehensive database searches up to November 2024. Data were analyzed using RevMan Web, employing a random‐effects model.

Results

Four RCTs involving a total of 339 IBD patients were included in this analysis. Among these, 167 patients (UC and CD) received the MD, whereas 172 followed non‐Mediterranean diets (NMD). The MD was associated with a statistically significant improvement in clinical remission compared with NMD (RR 1.18, p = 0.02). In subgroup analyses, clinical remission was not statistically different in UC (RR 1.15, 95% CI: 0.94–1.41, p = 0.78) or CD (RR 1.22, 95% CI: 1.00–1.47, p = 0.05). When compared specifically with a regular diet, MD significantly reduced both CRP levels (MD −2.66, p < 0.00001) and fecal calprotectin (MD −229.46, p = 0.008). Specifically, within the UC population, MD significantly decreased CRP and fecal calprotectin levels.

Discussion

Our findings indicate that the MD significantly benefits IBD management, especially UC, as demonstrated by notable reductions in inflammatory markers. Benefits in CD remain unclear despite prior evidence. Future research should clarify benefits across patient subgroups and address adherence challenges.

Förderung

  • Pennsylvania State University

Zitieren

APA

Shahzil, M., Kazmi, S. K., Shehzadi, M., Hasan, F., Danish, M. W., Faisal, M. S., Canakis, J., & Clarke, K. (2026). The Mediterranean Diet and Inflammatory Bowel Disease: A Comprehensive Systematic Review and Meta‐Analysis. Gastroenterology Research and Practice, 2026(1). https://doi.org/10.1155/grp/2994340

Vancouver

Shahzil M, Kazmi SK, Shehzadi M, Hasan F, Danish MW, Faisal MS, et al. The Mediterranean Diet and Inflammatory Bowel Disease: A Comprehensive Systematic Review and Meta‐Analysis. Gastroenterology Research and Practice. 2026;2026(1). doi:10.1155/grp/2994340

BibTeX
@article{Shahzil2026,
  author = {Shahzil, Muhammad and Kazmi, Syeda Kanza and Shehzadi, Minahel and Hasan, Fariha and Danish, Mohammad Waqas and Faisal, Muhammad Saad and Canakis, Justin and Clarke, Kofi},
  title = {The Mediterranean Diet and Inflammatory Bowel Disease: A Comprehensive Systematic Review and Meta‐Analysis},
  journal = {Gastroenterology Research and Practice},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/grp/2994340}
}
Kostenlos starten →